Abeona Therapeutics (ABEO) Gains from Investment Securities (2010 - 2026)

Abeona Therapeutics' Gains from Investment Securities history runs 16 years deep, the most recent figure standing at $335000.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 65.39% year-over-year to $335000.0; the TTM figure through Mar 2026 stood at -$3.6 million (up 33.38% YoY), while the FY2025 annual figure was $176019.0, changed 0.47% from the prior year.
• Gains from Investment Securities was $335000.0 for Q1 2026 at Abeona Therapeutics, up from -$6.6 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $8.6 million in Q2 2023 to a low of -$7.5 million in Q4 2023.
• Historically, Gains from Investment Securities has averaged -$61117.8 across 5 years, with a median of $178859.0 in 2024.
• Biggest YoY gain for Gains from Investment Securities was 36943.75% in 2022; the steepest drop was 305100.0% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at $5.9 million in 2022, then slumped by 227.43% to -$7.5 million in 2023, then surged by 100.11% to $8000.0 in 2024, then plunged by 82400.0% to -$6.6 million in 2025, then surged by 105.09% to $335000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $335000.0 (Q1 2026), -$6.6 million (Q4 2025), and -$2.8 million (Q3 2025), per Business Quant data.